Phase 3 — Large-scale testing across thousands of people, comparing the new treatment against current standard treatments.
Trial locations(24 sites)
United States
Mayo Clinic Arizona, Scottsdale, Arizona University of Colorado - Anschutz Medical, Aurora, Colorado Yale University School of Medicine, North Haven, Connecticut Mayo Clinic Florida, Jacksonville, Florida University of Illinois Chicago, Chicago, Illinois Northwestern University, Evanston, Illinois Indiana University, Indianapolis, Indiana University of Maryland, Baltimore, Baltimore, Maryland Johns Hopkins University, Baltimore, Maryland Harvard University Massachusetts General Hospital, Boston, Massachusetts Boston Medical Center, Boston, Massachusetts Mayo Clinic in Rochester, Rochester, Minnesota University of Mississippi Medical Center, Jackson, Mississippi Icahn School of Medicine at Mount Sinai, New York, New York Weill Cornell Medical College, New York, New York Duke University Health System, Durham, North Carolina Dean McGee Eye Institute at University of Oklahoma Health Sciences, Oklahoma City, Oklahoma Oregon Health & Sciences University, Portland, Oregon University of Pittsburgh Medical Center, Magee Hospital, Pittsburgh, Pennsylvania Vanderbilt University Medical Center, Nashville, Tennessee UT Southwestern Medical Center, Dallas, Texas University of Utah, Salt Lake City, Utah University of Virginia, Charlottesville, Virginia University of Washington, Seattle, Washington